Why BGPT?
logo

Assess an author's data and outputs

See the raw experimental evidence behind an author's publications and reproducibility signals.







Press Enter ↵ to solve



    Fuel Your Discoveries




     Quick Explanation



    David F. Boyd — evidence-based strength check (from provided records)
    Based on the two provided, source-grounded paper records, the scientific signal is moderate-to-strong, with one narrative review scoring higher on conceptual usefulness but only moderate reproducibility, and one virology/mechanism study showing higher methodological rigor and reproducibility—while both entries still have scope limits typical of their study types.



     Long Explanation



    Author Review: David F. Boyd (evidence strength from provided records only)
    ⚠️ Scope note: You provided (i) citation metrics + a list of paper titles/IDs (no DOIs), and (ii) two detailed paper records with DOIs and structured extracts. Per your constraints, I only make scientific claims that are directly supported by those two DOI-backed records below.
    1) Evidence map (what the provided records cover)
    • Record A (2017): narrative review synthesizing ECM–immune coupling and proposing integrative omics approaches (lung-focused contexts), with no primary data.
    • Record B (2016): experimental virology/mechanism study linking SHIV adaptation to Envelope (Env)-mediated IFN-α resistance, using replication assays with IFN-α, Env quantification, RT-qPCR, infectivity readouts, and Env-swap/chimeric tests.
    2) Visual comparison: quality signals from the provided structured scores
    Critical reading: these are provided score fields, not independent re-computation; treat them as a compact rubric summary, not as audited peer review outcomes. Still, the pattern matches typical study-type priors: the narrative review shows lower reproducibility score plausibly due to absence of primary datasets, while the experimental SHIV study shows higher reproducibility and methodological richness.
    3) Mechanistic credibility check (Record B) — what is strong vs what remains uncertain
    3.1 What the provided record supports (mechanism-linked)
    • Env content is central: the entry claims macaque-passaged/lab-adapted SHIVs show higher replication and IFN-α resistance, with correlations to virion Env content and chimera/Env-swap findings pointing to Env as the main determinant.
    • Post-transcriptional implication: the entry notes differences in Env protein exceeding Env mRNA differences, suggesting the resistance phenotype is not simply transcriptional upshift.
    3.2 Where the evidence is necessarily limited (counterpoints)
    • Model generalizability: the entry flags that in vitro systems and SHIV species-specific interactions constrain extrapolation to human infection dynamics.
    • Mechanism still not fully pinned: the entry suggests plausible mechanistic explanations (e.g., restriction-factor saturation or Env-mediated antagonism) but does not, within the provided record excerpt, fully resolve which downstream restriction nodes are engaged.
    4) Synthesis-quality check (Record A) — how strong is a narrative review for claims?
    4.1 Supported value
    • Integration framing: the entry states the review synthesizes ECM components, remodeling enzymes, matrikines, and their immune feedback roles, specifically arguing ECM and immunological pathways are tightly interconnected in lung contexts.
    • Omics-oriented proposal: the entry advocates integrative omics to map ECM–immune networks, citing mass spectrometry proteomics and RNA-seq/transcriptomics integration as conceptual tools.
    4.2 Narrative-review epistemic constraints
    • Selection and contextual bias risk: the entry flags narrative-review risks such as emphasis on recently highlighted interactions, tissue/species differences, and reliance on heterogeneous models that may not generalize causally.
    • No new primary datasets: per the entry, no primary data are generated; reproducibility depends on the underlying studies and how well they converge mechanistically.
    5) Record-grounded “strength scorecard” (only from the provided entries)
    Transparency: The scorecard is not extracted as a numeric field from your data; it is a conservative heuristic derived from (i) whether the record describes primary mechanistic tests, perturbations, and mapping, versus (ii) narrative synthesis without primary data, and (iii) the provided reproducibility/rigor style score signals.
    6) Overall scientific strength assessment (from the provided evidence only)
    • Strength: In the experimental virology/mechanism record, the evidence appears structured for causal inference around Env’s role in IFN-α resistance (multiple assay types + chimera/mapping logic), supporting a relatively high confidence in the stated determinant role—while still leaving “which downstream nodes of IFN restriction are targeted” as an open mechanistic question.
    • Strength: In the ECM–immune synthesis record, the value is in integrating concepts and proposing omics-centered network mapping strategies for ECM–immune coupling in lung contexts; the scientific limitation is that narrative synthesis is sensitive to which studies are emphasized and lacks new primary validation.
    • Red flag (data sufficiency): The current author review cannot robustly evaluate the author’s overall track record because the provided DOIs/record-extracts cover only two entries out of the many paper titles/IDs you listed.
    Run a broader DOI-grounded author review in BGPT
    This would require fetching and DOI-resolving the additional paper entries not included in the two DOI-backed records here.


    Feedback:   

    Updated: March 20, 2026

     Analysis Wizard



    Computes rubric-style score comparisons and visualizes the two provided Boyd records’ quality dimensions, enabling quick evidence-type contrast (narrative review vs mechanistic experiment).



     Hypothesis Graveyard



    “IFN-α resistance is primarily due to higher env mRNA transcription.” This is contradicted by the provided record’s claim that Env mRNA differences are comparatively small while Env protein/virion Env differences are much larger, pointing away from transcription-only explanations.


    “ECM–immune coupling is a purely correlational narrative without actionable omics structure.” This is challenged by the record’s explicit proposal of integrative proteomics/transcriptomics frameworks aimed at identifying ECM–immune networks, though causal validation remains limited for a narrative review.

     Science Art


    Author Review: David F Boyd Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT